A study led by Dr David Hughes (Centre for Systems Medicine, RCSI) examined the relevance of using a two sample quantitative immunochemical faecal occult blood test (FIT) at a high cut off stringency by the first population–based colorectal cancer (CRC) pilot screening programme in Ireland. The manuscript is online from June 10th 2013 in the journal Colorectal Disease*. The CRC miss rate estimated for a single test (23.5%) was unacceptably high when the goal was to maximize the discovery of advanced lesions in the initial screening round. The authors concluded that the two test protocol at a high cut off threshold is suitable to optimize FIT screening in Ireland.
- CSM Researchers and collaborators discover predictive biomarker for key colorectal cancer drug
- MSc students from the Netherlands visit the CSM
- Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22!
- PurinesDX conference April 24th RCSI
- ‘Breast-Predict’ have developed a tool that may predict how effective chemotherapy is likely to be in treating triple-negative breast cancer patients.
- GLIOTRAIN : European Training Network PhD Student Position available
- CoEN Award to CSM-Network of Centres of Excellence in Neurodegeneration
- GLIOTRAIN, Brain Tumor Ireland and RCSI Presents Two Public Lectures- Friday March 9th
- Physiology News Letter 2nd Edition January 2018
- JPND fund the CSM and its partners 1.5M